Lead Product(s) : Nilvadipine
Therapeutic Area : Neurology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Study shows Nilvadipine slows early-stage Alzheimer’s disease
Details : The data from the trial showed that early-stage Alzheimer’s patients who were taking Nilvadipine showed less cognitive decline over an 18-month period than patients treated with placebo.
Product Name : Nilvadil
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 06, 2020
Lead Product(s) : Nilvadipine
Therapeutic Area : Neurology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable